Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FATE Fate Therapeutics Inc

盘后交易 07-11 18:16:30 EDT

1.15

-0.01

-0.86%

盘后1.16

+0.01+0.87%

17:41 EDT

最高1.17	最低1.12	成交量103.91万
今开1.17	昨收1.16	日振幅4.31%
总市值1.32亿	流通市值1.06亿	总股本1.15亿
成交额118.93万	换手率1.13%	流通股本9,233万
市净率0.46	ROE-49.23%	每股收益-1.49
52周最高5.92	52周最低0.6611	市盈率-0.77
股息0.00	股息收益率0.00	ROA-23.97%

北京优虎网络科技有限公司

{"stockData":{"symbol":"FATE","market":"US","secType":"STK","nameCN":"Fate Therapeutics Inc","latestPrice":1.15,"timestamp":1752264000000,"preClose":1.16,"halted":0,"volume":1039135,"hourTrading":{"tag":"盘后","latestPrice":1.16,"preClose":1.15,"latestTime":"17:41 EDT","volume":15864,"amount":18252.970864799998,"timestamp":1752270075368},"delay":0,"floatShares":92329654,"shares":114633022,"eps":-1.490462,"marketStatus":"盘后交易","change":-0.01,"latestTime":"07-11 18:16:28 EDT","open":1.17,"high":1.17,"low":1.12,"amount":1189330.4298514999,"amplitude":0.043103,"askPrice":1.16,"askSize":200,"bidPrice":1.14,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.490462,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752278400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1380600000000,"exchange":"NASDAQ","adjPreClose":1.16,"preHourTrading":{"tag":"盘前","latestPrice":1.14,"preClose":1.16,"latestTime":"09:29 EDT","volume":1527,"amount":1768.4500035,"timestamp":1752240599999},"postHourTrading":{"tag":"盘后","latestPrice":1.16,"preClose":1.15,"latestTime":"17:41 EDT","volume":15864,"amount":18252.970864799998,"timestamp":1752270075368},"volumeRatio":0.800434,"impliedVol":0.9432,"impliedVolPercentile":0.384},"requestUrl":"/m/hq/s/FATE","defaultTab":"news","newsList":[{"id":"2537647747","title":"Fate Therapeutics, Inc.盘中异动 下午盘急速上涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537647747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537647747?lang=zh_cn&edition=full","pubTime":"2025-05-21 02:06","pubTimestamp":1747764416,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日02时06分，Fate Therapeutics, Inc.股票出现异动，股价急速拉升5.69%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Eyenovia, Inc.涨幅较大，Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃，换手率分别为5079.94%、1627.75%、1152.45%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为174.55%、118.06%、104.35%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020656a6e65a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521020656a6e65a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2536687170","title":"Fate Therapeutics, Inc.盘中异动 股价大涨6.54%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536687170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536687170?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:35","pubTimestamp":1747661705,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时35分，Fate Therapeutics, Inc.股票出现波动，股价急速拉升6.54%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.涨幅较大，Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为7239.83%、4586.37%、2035.64%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、再鼎医药、Tectonic Therapeutic, Inc.，振幅分别为290.57%、106.69%、102.91%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213505a4842432&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213505a4842432&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2535314849","title":"Fate Therapeutics, Inc.盘中异动 早盘大幅上涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535314849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535314849?lang=zh_cn&edition=full","pubTime":"2025-05-16 22:50","pubTimestamp":1747407050,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日22时50分，Fate Therapeutics, Inc.股票出现异动，股价快速上涨5.45%。截至发稿，该股报1.07美元/股，成交量35.8767万股，换手率0.31%，振幅5.94%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为3784.45%、2238.82%、1188.69%，振幅较大的相关个股有Affimed N.V.、Vor Biopharma Inc.、Imunon, Inc.，振幅分别为466.98%、65.59%、42.74%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516225050a6e1cb47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516225050a6e1cb47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2535875087","title":"Fate Therapeutics, Inc.盘中异动 快速拉升5.21%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535875087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535875087?lang=zh_cn&edition=full","pubTime":"2025-05-16 00:26","pubTimestamp":1747326380,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日00时26分，Fate Therapeutics, Inc.股票出现异动，股价急速上涨5.21%。截至发稿，该股报1.010美元/股，成交量35.6787万股，换手率0.31%，振幅7.75%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516002620975add84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516002620975add84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FATE","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2535307371","title":"Fate Therapeutics, Inc.盘中异动 快速上涨7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535307371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535307371?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:33","pubTimestamp":1747229612,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时33分，Fate Therapeutics, Inc.股票出现波动，股价急速上涨7.00%。截至发稿，该股报1.07美元/股，成交量7.863万股，换手率0.07%，振幅2.00%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Septerna, Inc.、蓝鸟生物、Quoin Pharmaceuticals Ltd涨幅较大，Nucana Plc、Quoin Pharmaceuticals Ltd、Polyrizon Ltd.较为活跃，换手率分别为2039.02%、1197.83%、1148.69%，振幅较大的相关个股有Nucana Plc、Septerna, Inc.、Quoin Pharmaceuticals Ltd，振幅分别为23.40%、15.45%、14.94%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213332a6df0919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213332a6df0919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","FATE"],"gpt_icon":0},{"id":"2535027111","title":"Baird：维持Fate Therapeutics(FATE.US)评级，由中性调整至中性评级, 目标价由5.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535027111","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535027111?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:28","pubTimestamp":1747229298,"startTime":"0","endTime":"0","summary":"Baird：维持Fate Therapeutics(FATE.US)评级，由中性调整至中性评级, 目标价由5.00美元调整至4.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14212850393816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FATE"],"gpt_icon":0},{"id":"2534115641","title":"Fate Therapeutics, Inc.盘中异动 大幅上涨5.00%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534115641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534115641?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:07","pubTimestamp":1746720434,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日00时07分，Fate Therapeutics, Inc.股票出现波动，股价大幅拉升5.00%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.42%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Nucana Plc、Gri Bio, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为495.95%、114.16%、65.30%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为87.50%、69.37%、59.60%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509000714aa2c87ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509000714aa2c87ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2533580154","title":"Fate Therapeutics, Inc.盘中异动 大幅跳水5.34%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533580154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533580154?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:54","pubTimestamp":1746453272,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时54分，Fate Therapeutics, Inc.股票出现异动，股价急速跳水5.34%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Nucana Plc、Scisparc Ltd.、Polyrizon Ltd.较为活跃，换手率分别为785.05%、447.77%、57.78%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Scisparc Ltd.、Nucana Plc，振幅分别为113.27%、43.94%、38.70%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050521543394ecf5ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050521543394ecf5ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2532873384","title":"Fate Therapeutics, Inc.盘中异动 下午盘股价大涨5.24%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532873384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532873384?lang=zh_cn&edition=full","pubTime":"2025-05-03 02:00","pubTimestamp":1746208850,"startTime":"0","endTime":"0","summary":"北京时间2025年05月03日02时00分，Fate Therapeutics, Inc.股票出现异动，股价急速拉升5.24%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Polyrizon Ltd.、Impact Biomedical, Inc.、Inozyme Pharma, Inc.涨幅较大，Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃，换手率分别为1395.39%、813.77%、737.79%，振幅较大的相关个股有Polyrizon Ltd.、Impact Biomedical, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为267.88%、119.72%、71.36%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503020050974d879b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503020050974d879b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2531205962","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531205962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531205962?lang=zh_cn&edition=full","pubTime":"2025-04-30 22:21","pubTimestamp":1746022877,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时21分，Fate Therapeutics, Inc.股票出现异动，股价大幅拉升5.13%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc C/Wts 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Onconetix, Inc.较为活跃，换手率分别为139.27%、27.91%、13.10%，振幅较大的相关个股有Nutriband Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为29.23%、25.02%、24.50%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430222118a6cef32a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430222118a6cef32a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","FATE","BK4139"],"gpt_icon":0},{"id":"2531756943","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531756943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531756943?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:09","pubTimestamp":1745935781,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时09分，Fate Therapeutics, Inc.股票出现波动，股价急速下挫5.60%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.52%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为141.78%、84.52%、26.70%，振幅较大的相关个股有Spruce Biosciences, Inc.、Ibio, Inc.、Cyclacel Pharmaceuticals, Inc.，振幅分别为41.73%、33.33%、26.68%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429220941974a44de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429220941974a44de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2530300391","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.11%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530300391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530300391?lang=zh_cn&edition=full","pubTime":"2025-04-25 22:22","pubTimestamp":1745590934,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日22时22分，Fate Therapeutics, Inc.股票出现波动，股价大幅下挫5.11%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Revolution Medicines Inc C/Wts 17/12/2026 、Transcode Therapeutics, Inc.涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为245.64%、90.30%、45.26%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Azitra Inc，振幅分别为90.48%、47.09%、29.12%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252222149745226f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252222149745226f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FATE"],"gpt_icon":0},{"id":"2529682249","title":"Fate Therapeutics, Inc.盘中异动 股价大涨7.30%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529682249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529682249?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415059,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分，Fate Therapeutics, Inc.股票出现异动，股价大幅拉升7.30%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Rezolute, Inc.涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为2743.21%、17.71%、7.88%，振幅较大的相关个股有Psyence Biomedical Ltd.、Immunocore Hldgs Plc、Ocean Biomedical, Inc.，振幅分别为9.34%、8.64%、7.79%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213059a463f8f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213059a463f8f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2529807294","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529807294?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:47","pubTimestamp":1745243251,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时47分，Fate Therapeutics, Inc.股票出现波动，股价大幅上涨5.41%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Dogwood Therapeutics, Inc.、Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为768.34%、322.19%、199.45%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Aptevo Therapeutics Inc.，振幅分别为38.20%、27.03%、23.20%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214731a6c27505&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421214731a6c27505&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2528774368","title":"Fate Therapeutics, Inc.盘中异动 早盘急速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528774368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528774368?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:37","pubTimestamp":1744897061,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时37分，Fate Therapeutics, Inc.股票出现异动，股价大幅上涨5.24%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为396.83%、143.97%、45.38%，振幅较大的相关个股有Channel Therapeutics Corporation、Sol-Gel Technologies Ltd.、Portage Biotech Inc.，振幅分别为35.06%、15.63%、14.67%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213741973b52ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213741973b52ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2527520417","title":"Fate Therapeutics, Inc.盘中异动 股价大涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527520417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527520417?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:38","pubTimestamp":1744724281,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时38分，Fate Therapeutics, Inc.股票出现异动，股价大幅拉升6.03%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Mural Oncology Plc、Verve Therapeutics, Inc.、Prokidney Corp.涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为436.42%、206.38%、81.82%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.，振幅分别为80.08%、47.57%、38.78%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213802a6bb4ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415213802a6bb4ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","FATE","LENZ"],"gpt_icon":0},{"id":"2526619857","title":"Fate Therapeutics, Inc.盘中异动 股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526619857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526619857?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:42","pubTimestamp":1744393322,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时42分，Fate Therapeutics, Inc.股票出现异动，股价快速拉升5.46%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.70%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2117.01%、1650.94%、398.97%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014203a456682a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014203a456682a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2518149227","title":"Fate Therapeutics, Inc.盘中异动 早盘快速下挫5.66%报0.953美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518149227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518149227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:50","pubTimestamp":1741614611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时50分，Fate Therapeutics, Inc.股票出现异动，股价大幅下挫5.66%。截至发稿，该股报0.953美元/股，成交量11.0385万股，换手率0.10%，振幅2.97%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2739.31%、617.86%、95.77%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021501196403af3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021501196403af3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","BK4139","LENZ"],"gpt_icon":0},{"id":"2518788289","title":"Fate Therapeutics, Inc.2024财年实现净利润-1.86亿美元，同比减少15.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518788289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518788289?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536051,"startTime":"0","endTime":"0","summary":"3月10日，Fate Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.86亿美元，同比减少15.53%；其中营业收入为13.63百万美元，同比减少78.55%，每股基本收益为-1.64美元。机构评级：截至2025年3月10日，当前有11家机构对Fate Therapeutics, Inc.目标价做出预测，其中目标均价为6.64美元，其中最低目标价为3.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000116abf1752b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000116abf1752b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FATE","LENZ"],"gpt_icon":0},{"id":"2517758162","title":"Stifel：维持Fate Therapeutics(FATE.US)评级，由持有调整至持有评级, 目标价由5.00美元调整至3.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517758162","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517758162?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:05","pubTimestamp":1741277144,"startTime":"0","endTime":"0","summary":"Stifel：维持Fate Therapeutics(FATE.US)评级，由持有调整至持有评级, 目标价由5.00美元调整至3.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07000548577051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["FATE","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fatetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.3054},{"period":"3month","weight":0.0943},{"period":"6month","weight":-0.2082},{"period":"1year","weight":-0.6282},{"period":"ytd","weight":-0.297}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fate Therapeutics, Inc.于2007年4月27日在特拉华州合并，是一家临床分期生物制药公司，致力于成体干细胞治疗调节器的探索与开发，治疗罕见疾病，包括一些恶性血液病、溶酶体贮积症和肌肉营养不良。Fate使用的一些新方法采用已有的治疗模式，包括小分子和治疗性蛋白，并瞄准良好的生物机制，以增强成体干细胞的疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.03599},{"month":2,"riseRate":0.583333,"avgChangeRate":0.064289},{"month":3,"riseRate":0.5,"avgChangeRate":-0.006528},{"month":4,"riseRate":0.583333,"avgChangeRate":0.001011},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.020051},{"month":6,"riseRate":0.5,"avgChangeRate":0.003206},{"month":7,"riseRate":0.5,"avgChangeRate":0.054662},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.021881},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.018445},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.106424},{"month":11,"riseRate":0.583333,"avgChangeRate":0.111361},{"month":12,"riseRate":0.583333,"avgChangeRate":0.060305}],"exchange":"NASDAQ","name":"Fate Therapeutics Inc","nameEN":"Fate Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fate Therapeutics Inc,FATE,Fate Therapeutics Inc股票,Fate Therapeutics Inc股票老虎,Fate Therapeutics Inc股票老虎国际,Fate Therapeutics Inc行情,Fate Therapeutics Inc股票行情,Fate Therapeutics Inc股价,Fate Therapeutics Inc股市,Fate Therapeutics Inc股票价格,Fate Therapeutics Inc股票交易,Fate Therapeutics Inc股票购买,Fate Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}